[1]
Z. Ullah, S. Z. Khan, H. Lodhi, H. Khan, R. Hidayat, and M. Ahmed, “Efficacy of Sofosbuvir and Daclatasvir in Achieving the End Treatment Response and Sustained Viral Response in Patients infected with Hepatitis C Virus Genotype 3”, Pak Armed Forces Med J, vol. 72, no. 3, pp. 1074–77, Jun. 2022, doi: 10.51253/pafmj.v72i3.4470.